https://www.selleckchem.com/pr....oducts/cx-4945-silmi
Modification of sEV glycosylation may contribute to development of novel targets in breast cancer therapy.Exosome extracellular vesicles as biologic therapy for COVID-19 are discussed for two areas. The first involves the growing use of mesenchymal stromal cells (MSCs) for the profound clinical cytokine storm and severe pneumonia in COVID-19 patients. Instead, it is recommended to treat alternatively with their MSC-released exosomes. This is because many reports in the literature and our data have shown that the release of
Like
Comment
Share
